Aprogen Pharmaceuticals Inc (003060) — Strategic Asset Allocation Index
Aprogen Pharmaceuticals Inc (003060) has a Strategic Asset Allocation Index of 3.0% as of September 2022. Strategic assets (PP&E of ₩18.38 Billion plus long-term investments of ₩-) total ₩18.38 Billion, measured against net assets of ₩604.45 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Aprogen Pharmaceuticals Inc Strategic Asset Allocation Index (2009–2021)
This chart shows how Aprogen Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2021. As of September 2022, the index stands at 3.0%, representing strategic assets of ₩18.38 Billion against net assets of ₩604.45 Billion KRW. Explore 003060 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Aprogen Pharmaceuticals Inc (2009–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Aprogen Pharmaceuticals Inc from 2009 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Aprogen Pharmaceuticals Inc (003060) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.2% | ₩18.86 Billion | ₩18.86 Billion | ₩- | ₩597.18 Billion | ▼ -0.2 pp |
| 2020 | 3.3% | ₩19.80 Billion | ₩19.80 Billion | ₩- | ₩598.36 Billion | ▼ -36.4 pp |
| 2019 | 39.7% | ₩137.87 Billion | ₩45.91 Billion | ₩91.97 Billion | ₩347.64 Billion | ▼ -43.3 pp |
| 2018 | 82.9% | ₩124.85 Billion | ₩17.33 Billion | ₩107.52 Billion | ₩150.51 Billion | ▼ -21.1 pp |
| 2017 | 104.1% | ₩81.05 Billion | ₩18.16 Billion | ₩62.88 Billion | ₩77.86 Billion | ▲ +59.1 pp |
| 2016 | 45.0% | ₩35.16 Billion | ₩25.95 Billion | ₩9.21 Billion | ₩78.12 Billion | ▲ +6.4 pp |
| 2015 | 38.6% | ₩26.13 Billion | ₩25.11 Billion | ₩1.02 Billion | ₩67.75 Billion | ▼ -8.0 pp |
| 2014 | 46.6% | ₩28.91 Billion | ₩22.59 Billion | ₩6.33 Billion | ₩62.11 Billion | ▼ -1.0 pp |
| 2013 | 47.5% | ₩26.88 Billion | ₩21.20 Billion | ₩5.69 Billion | ₩56.55 Billion | ▲ +29.2 pp |
| 2012 | 18.3% | ₩12.54 Billion | ₩12.54 Billion | ₩- | ₩68.51 Billion | ▼ -8.8 pp |
| 2011 | 27.1% | ₩19.90 Billion | ₩19.90 Billion | ₩- | ₩73.49 Billion | ▼ -26.7 pp |
| 2010 | 53.8% | ₩23.02 Billion | ₩23.02 Billion | ₩- | ₩42.81 Billion | ▲ +29.6 pp |
| 2010 | 24.2% | ₩10.02 Billion | ₩10.02 Billion | ₩- | ₩41.38 Billion | ▼ -1.5 pp |
| 2009 | 25.7% | ₩6.47 Billion | ₩6.47 Billion | ₩- | ₩25.18 Billion | — |